Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):537. doi: 10.1158/1055-9965.EPI-09-0898

Table 2.

Characteristics of premenopausal women in the study population: Group Health, Seattle, WA 2004 – 2005 (N = 175*)

Age, y
 Mean (SD) 42.4 (1.4)
 Median (Range) 43.0 (40, 45)
Age at menarche, y
 Mean (SD) 12.8 (1.3)
 Median (Range) 13.0 (10, 17)
Age at first birth§, y
 Mean (SD) 28.8 (5.9)
 Median (Range) 29.0 (15, 40)
Body mass index, kg/m2
 Mean (SD) 25.8 (4.6)
 Median (Range) 25.0 (19, 39)
Height, m
 Mean (SD) 1.65 (0.07)
 Median (Range) 1.65 (1.48, 1.84)
Weight, kg
 Mean (SD) 70.4 (13.3)
 Median (Range) 68.0 (46, 108)
Waist:Hip ratio
 Mean (SD) 0.79 (0.06)
 Median (Range) 0.78 (0.66, 1.00)

n (%)

Number of live births
 0 50 (28.6)
 1 23 (13.1)
 2+ 83 (47.4)
Had a history of breast-feeding§ 100 (81.3)
Had a history of hormone use 125 (71.4)
First degree relative with breast and/or ovarian cancer 22 (12.6)
Smoking status
 Current 8 (4.6)
 Former 54 (30.9)
 Never 119 (68.0)
Race / ethnicity
 Asian 13 (7.4)
 White 152 (86.9)
 Other 8 (4.6)
Years of school completed
 ≤ 12 12 (6.9)
 13 – 15 48 (27.4)
 16 49 (28.0)
 ≥ 17 years 64 (36.6)
Income
 ≤ $49,999 28 (16.0)
 $50,000 – $75,000 41 (23.4)
 > $75,000 83 (47.4)
 No information provided 21 (12.0)
*

Numbers (%) may not add up to 175 (100%) for some characteristics due to missing values and rounding calculations

§

Among parous women only (n = 123);

Use of oral contraceptives, hormone patches, hormone injections, hormone implants, or intrauterine devices containing progesterone at any time prior to the 6-month period before the screening mammogram